US FDA Frees Dr. Reddy’s Mexican Unit from Import Alert
Submitted by Neeraj Shahane on Sat, 07/28/2012 - 12:27
Recent reports suggest that Dr. Reddy's Laboratories Ltd. Unit at Mexico has been granted the approval to import products to United States. It has been reported that the Mexican chemical company was being inspected by US Food and Drug Administration.
Concerns over Metal-On-Metal-Hip Replacements
Submitted by Dinesh Chandra Gaur on Sat, 06/30/2012 - 12:54
Other medical equipment has gained attention, after the PIP implant issue and it is none other than metal-on-metal hip implants. Experts seem to be remaining confused as whether it should be recommended to patients or not.
FDA Extends Approval Period for New Pain Drug
Submitted by Dinesh Chandra Gaur on Sat, 06/30/2012 - 10:11
A report has unveiled recently that a new drug, MoxDuo, proposed by QRxPharma for approval, has been refused to be passed currently by the US Food and Drug Administration.
As per the findings, the FDA suspects the drug to be unsafe as yet to be recommended for public use. And thus, it has also asked the company to conduct more trials and provide more details regarding the same.
FDA Finally Approves Arena's Weight-loss Drug Belviq
Submitted by Dinesh Chandra Gaur on Thu, 06/28/2012 - 11:03
Finally, medical industry will start giving solutions for obesity and relaxation to obese people for a long time from their heavy weights. Above hopes are following the recent decision of Food and Drug Administration, in which they have decided to give approval to Arena Pharmaceuticals' anti-obesity pill Belviq.
FDA Issues Norovirus Warning Against Korean Seafood
Submitted by Neeraj Shahane on Fri, 06/15/2012 - 12:56
A warning has been issued by the US Food and Drug Administration on procurement and sale of imported oysters, clams, mussels and some types of scallops from Korea. FDA is of the view that they might be contaminated with Norovirus.
FDA Approves Drug for Treating Restless Leg Syndrome
Submitted by Dinesh Chandra Gaur on Fri, 06/08/2012 - 12:37
As per recent reports, it has been reported that US Food and Drug Administration has approved drug manufactured by drugmaker XenoPort Inc and partner GlaxoSmithKline Plc, for treating shingles-related nerve pain.
